Fire forces Puvirnituq, Que., to declare state of emergency as water shortage continues
As people in Puvirnituq, Que., continue to struggle with a worsening water shortage, a fire has prompted the small village in Nunavik to declare a state of emergency.
The fire, which began Saturday at around 3 p.m., destroyed two housing units in the village of 2,100 people.
No injuries were reported but the firefighters' inability to deal with the fire quickly due to a limited supply of water is what led to a state of emergency being declared, according to Radio-Canada.
Access to water has been limited since a pipe that connects the pump station to the treatment plant froze in mid-March.
In recent days, patients have had to be flown south due to the limited water supply in hospitals and there have been growing concerns about sicknesses like gastroenteritis (stomach flu) spreading rapidly because of many people are unable to wash their hands.
CBC News is reaching out to local authorities in order to get a better sense of what a declaration of a state of emergency entails.
"I feel for our community," Puvirnituq Mayor Lucy Qalingo wrote on Facebook late Saturday night. "I don't know what else to say."
Earlier that day, hours before the fire started, the mayor had also taken to Facebook to say that "both governments should stop ignoring the high needs of everything in Nunavik" and issued an urgent call for help, writing: "Please don't fail us."
"If we don't see changes from the result of the crisis we are going through, we are definitely nothing to them. What we are going through right now happens in third world countries," Qalingo wrote in the Facebook post.
"We don't have to beg for water. We are also Canadians. Forgotten Canadians."
CBC News also has reached out to the office of Ian Lafrenière — Quebec's minister responsible for relations with the First Nations and the Inuit — as well as the office of Canada's new Indigenous Services Minister Mandy Gull-Masty.
Earlier this week, Lafrenière said he had been in touch with the Kativik Regional Government and the Nunavik Regional Board of Health and Social Services for the past three weeks and that his government was ready to provide assistance.
Two planes loaded with water left Montreal for Puvirnituq on Friday morning. The province's ministry of public security said three more water deliveries were scheduled over the weekend, though weather conditions could affect those operations.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Marc Garneau died after 'short but very difficult battle' with cancer, former staffer says
Marc Garneau died this week after being diagnosed with two types of cancer earlier this year, his former staffer says. The first Canadian to travel to space and former cabinet minister died on Wednesday. He was 76. Marc Roy, Garneau's former chief of staff, told CBC's Power & Politicsthat the former minister had been diagnosed with lymphoma and leukemia earlier this year. "He fought a short but very difficult battle with two very rare types of cancer," Roy told host David Cochrane. "Although his diagnosis was only a couple of months ago, he was well until four or five weeks ago. So it went very, very quickly … it's a very, very tough loss." Roy said Garneau only shared his diagnosis with a small circle that agreed to respect his wish for privacy. "[It was] something he wanted to keep with his family so he could concentrate on his time with his family and not distract his family by the attention it could have gotten," Roy said. WATCH | It's a tragic loss,' says former chief of staff: Beyond his legacy as an astronaut, Garneau held a number of federal cabinet positions since 2015, including in transport and foreign affairs. Roy said Garneau was "tremendous" to work for as he reflected on his time in politics. "It's a huge loss to government. I think that his years in Ottawa are filled with many contributions to improving safety and expanding policy. I think he will be remembered for that for decades to come," Roy said. The House of Commons held another moment of silence for Garneau on Thursday and MPs took time to pay tribute to their former colleague. "He reminded us that Canadians can dream big, that we could aim for the stars quite literally," Government House leader Steve MacKinnon said. "He became a powerful symbol of the achievement and the accomplishment of this great country of ours." Like MacKinnon, other MPs reflected on how Garneau inspired Canadians. "Mr. Garneau, the future will always be inspired by your life, which was so inspiring for all Canadians," Conservative MP Gérard Deltell said in French. WATCH | Garneau's 'extraordinary ride': Bloc Québécois MP Rhéal Fortin said Garneau paved the way for other Canadians to journey to space, including Chris Hadfield and Julie Payette. "He showed us the way to the stars," Fortin said in French. Fighting back tears, Green Party Leader Elizabeth May said it was hard to say goodbye to "someone who was unfailingly kind [and] unfailingly respectful." "We've lost a very great human being, and to his entire family: my deepest condolences and sympathy — and know that in that space where he looks down at planet Earth now, I think it's a place called heaven."
Yahoo
an hour ago
- Yahoo
Canada Glucose Monitoring Device Market Forecast & Opportunities, 2025-2030: Increasing Adoption of Advanced Glucose Monitoring Technologies
The Canada glucose monitoring device market is expanding due to rising diabetes cases and technological advancements. Key opportunities include increased demand for continuous and flash glucose monitors for proactive management. However, high costs limit access, especially for uninsured patients. Advanced CGMs and data-integrated solutions offer growth potential. Canadian Glucose Monitoring Device Market Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Canada Glucose Monitoring Device Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" has been added to offering. The Canada Glucose Monitoring Device Market was valued at USD 1.23 Billion in 2024 and is expected to reach USD 2.54 Billion by 2030, rising at a CAGR of 12.85% The market is witnessing significant expansion driven by rapid technological advancements and the rising prevalence of diabetes across the country. With diabetes recognized as a pressing public health concern, demand for efficient glucose monitoring tools has surged. According to Health Canada, the global diabetic population is expected to more than double by 2050, underscoring the urgent need for accessible monitoring solutions. As a major contributor to global morbidity and mortality, diabetes has propelled the adoption of devices like continuous and flash glucose monitors, which offer real-time data and enable proactive disease management. Rising Prevalence of Diabetes in Canada The growing number of diabetes cases across Canada is a critical factor driving the glucose monitoring device market. By 2020-2021, approximately 3.7 million Canadians, or 9.4% of the population aged one and above, were diagnosed with diabetes, a figure that climbs to 27% among those aged 65 and older. This demographic shift underscores the escalating need for effective blood sugar monitoring tools. Devices such as continuous glucose monitors (CGMs) and flash glucose monitors (FGMs) have become essential for real-time tracking and management of glucose levels. They support timely interventions and help mitigate complications like cardiovascular disease, kidney damage, and neuropathy, thereby improving patient outcomes and quality of life. High Cost of Advanced Monitoring Devices The cost of advanced glucose monitoring technologies remains a major hurdle to widespread use. While some government programs offer financial assistance, not all individuals qualify, and personal expenses can be steep. For instance, individuals with type 1 diabetes in Alberta may face up to $7,000 in annual out-of-pocket expenses, while those with type 2 diabetes could spend as much as $6,000. These costs include the initial device, sensors, and transmitters, which can be financially burdensome for patients lacking sufficient insurance coverage. This financial barrier often restricts access to newer technologies, affecting diabetes care and control among economically vulnerable populations. Adoption of Advanced Glucose Monitoring Technologies A prominent trend in the Canadian market is the increasing shift towards advanced glucose monitoring systems, particularly CGMs. These devices deliver continuous glucose readings, offering superior glycemic management and reducing complications such as hypo- and hyperglycemia. Compared to traditional finger-prick methods, CGMs enhance user convenience and improve quality of life. Integration with insulin pumps and mobile apps has enabled real-time data sharing and automated insulin delivery, allowing healthcare providers to personalize treatment plans more effectively. As awareness of these benefits grows, the uptake of advanced glucose monitoring technologies is expected to rise steadily across Canada. Key Attributes: Report Attribute Details No. of Pages 70 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $1.23 Billion Forecasted Market Value (USD) by 2030 $2.54 Billion Compound Annual Growth Rate 12.8% Regions Covered Canada Report Scope Key Market Players: Medtronic of Canada Ltd Abbott Canada. Johnson & Johnson Inc/Canada Braun of Canada F. Hoffmann-La Roche Limited. Ascensia Diabetes Care. Sanofi-Aventis Canada Inc. Eli Lilly Canada Inc. Canada Glucose Monitoring Device Market, By Product Type: Self-Blood Glucose Monitoring Devices Continuous Glucose Monitoring Devices Canada Glucose Monitoring Device Market, By Application: Type 1 Diabetes Type 2 Diabetes Gestational Diabetes Canada Glucose Monitoring Device Market, By End User: Home Care Settings Hospital Others Canada Glucose Monitoring Device Market, By Region: Ontario Quebec Alberta British Columbia Saskatchewan and Manitoba Rest of Canada For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Canadian Glucose Monitoring Device Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
an hour ago
- Yahoo
Canada Glucose Monitoring Device Market Forecast & Opportunities, 2025-2030: Increasing Adoption of Advanced Glucose Monitoring Technologies
The Canada glucose monitoring device market is expanding due to rising diabetes cases and technological advancements. Key opportunities include increased demand for continuous and flash glucose monitors for proactive management. However, high costs limit access, especially for uninsured patients. Advanced CGMs and data-integrated solutions offer growth potential. Canadian Glucose Monitoring Device Market Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Canada Glucose Monitoring Device Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" has been added to offering. The Canada Glucose Monitoring Device Market was valued at USD 1.23 Billion in 2024 and is expected to reach USD 2.54 Billion by 2030, rising at a CAGR of 12.85% The market is witnessing significant expansion driven by rapid technological advancements and the rising prevalence of diabetes across the country. With diabetes recognized as a pressing public health concern, demand for efficient glucose monitoring tools has surged. According to Health Canada, the global diabetic population is expected to more than double by 2050, underscoring the urgent need for accessible monitoring solutions. As a major contributor to global morbidity and mortality, diabetes has propelled the adoption of devices like continuous and flash glucose monitors, which offer real-time data and enable proactive disease management. Rising Prevalence of Diabetes in Canada The growing number of diabetes cases across Canada is a critical factor driving the glucose monitoring device market. By 2020-2021, approximately 3.7 million Canadians, or 9.4% of the population aged one and above, were diagnosed with diabetes, a figure that climbs to 27% among those aged 65 and older. This demographic shift underscores the escalating need for effective blood sugar monitoring tools. Devices such as continuous glucose monitors (CGMs) and flash glucose monitors (FGMs) have become essential for real-time tracking and management of glucose levels. They support timely interventions and help mitigate complications like cardiovascular disease, kidney damage, and neuropathy, thereby improving patient outcomes and quality of life. High Cost of Advanced Monitoring Devices The cost of advanced glucose monitoring technologies remains a major hurdle to widespread use. While some government programs offer financial assistance, not all individuals qualify, and personal expenses can be steep. For instance, individuals with type 1 diabetes in Alberta may face up to $7,000 in annual out-of-pocket expenses, while those with type 2 diabetes could spend as much as $6,000. These costs include the initial device, sensors, and transmitters, which can be financially burdensome for patients lacking sufficient insurance coverage. This financial barrier often restricts access to newer technologies, affecting diabetes care and control among economically vulnerable populations. Adoption of Advanced Glucose Monitoring Technologies A prominent trend in the Canadian market is the increasing shift towards advanced glucose monitoring systems, particularly CGMs. These devices deliver continuous glucose readings, offering superior glycemic management and reducing complications such as hypo- and hyperglycemia. Compared to traditional finger-prick methods, CGMs enhance user convenience and improve quality of life. Integration with insulin pumps and mobile apps has enabled real-time data sharing and automated insulin delivery, allowing healthcare providers to personalize treatment plans more effectively. As awareness of these benefits grows, the uptake of advanced glucose monitoring technologies is expected to rise steadily across Canada. Key Attributes: Report Attribute Details No. of Pages 70 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $1.23 Billion Forecasted Market Value (USD) by 2030 $2.54 Billion Compound Annual Growth Rate 12.8% Regions Covered Canada Report Scope Key Market Players: Medtronic of Canada Ltd Abbott Canada. Johnson & Johnson Inc/Canada Braun of Canada F. Hoffmann-La Roche Limited. Ascensia Diabetes Care. Sanofi-Aventis Canada Inc. Eli Lilly Canada Inc. Canada Glucose Monitoring Device Market, By Product Type: Self-Blood Glucose Monitoring Devices Continuous Glucose Monitoring Devices Canada Glucose Monitoring Device Market, By Application: Type 1 Diabetes Type 2 Diabetes Gestational Diabetes Canada Glucose Monitoring Device Market, By End User: Home Care Settings Hospital Others Canada Glucose Monitoring Device Market, By Region: Ontario Quebec Alberta British Columbia Saskatchewan and Manitoba Rest of Canada For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Canadian Glucose Monitoring Device Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900